Could a pill replace daily shots for growth hormone deficiency?
NCT ID NCT05250063
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an oral drug called LUM-201 in 15 children with growth hormone deficiency who had already received daily injections for a year. The goal was to see if LUM-201 could maintain or improve growth over 12 months. The drug was given once daily by mouth, and researchers measured height changes and monitored for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LUM-201 (oral drug)
What this could lead to
If successful, this could offer a more convenient oral treatment option for children with growth hormone deficiency, reducing the need for daily injections.
What could go wrong
This is a small, early-phase study with only 15 participants, so results may not apply to all children. The drug may not work as well as current treatments or could have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROWTH HORMONE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Indiana University School of Medicine
Indianapolis, Indiana, 46202, United States
-
Klinika Endokrynologii i Chorob Metabolicznych, Instytut Centrum Zdrowia Matki Polki
Lodz, Poland
-
Klinika Endokrynologii i Diabetologii, Instytut "Pomnik Centrum Zdrowia Dziecka
Warsaw, Poland
-
M Health, Fairview Pediatric Specialty Clinics- Discovery Clinic
Minneapolis, Minnesota, 55454, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
-
Rady Children's Hospital
San Diego, California, 92123, United States
-
Sonomed - Centrum Medyczne
Szczecin, Poland
-
The Children's Mercy Hospital
Kansas City, Missouri, 64111, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States